NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that Zacks Small Cap Research (“Zacks SCR”) has initiated coverage on the company. Zacks SCR coverage maintains a specific focus on small and micro-cap companies that are believed to be undervalued and well-positioned for future growth. Zacks SCR analysts seek to identify and report on these companies, bringing to investors a unique opportunity to gain insight through its high quality (“institutional”) research for the small cap portfolio. To access the PBIO report, visit: http://nnw.fm/eYr9S
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer